2025未来医疗医药100强展会落幕，智翔金泰双奖加持彰显生物技术创新实力

智翔金泰生物2025-05-12

2025年5月9日-10日，由动脉网主办的2025未来医疗医药100强展会（2025VBEF）在苏州国际博览中心举行。大会上，重庆智翔金泰生物制药股份有限公司（简称“智翔金泰”）凭借在生物技术创新领域的卓越表现荣登“2025未来医疗100强医疗健康上市企业创新力排行榜TOP100”，其自主研发的斯乐韦米单抗注射液（乐比孚®）凭借突出的临床价值和市场潜力荣获2025未来医疗100强创新奖类“最佳...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2534089214?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-12 09:42","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2534089214","market":"sh","top_or_hot":-1,"title":"2025未来医疗医药100强展会落幕，智翔金泰双奖加持彰显生物技术创新实力","media":"智翔金泰生物","content":"<div>\n<p>2025年5月9日-10日，由动脉网主办的2025未来医疗医药100强展会（2025VBEF）在苏州国际博览中心举行。大会上，重庆智翔金泰生物制药股份有限公司（简称“智翔金泰”）凭借在生物技术创新领域的卓越表现荣登“2025未来医疗100强医疗健康上市企业创新力排行榜TOP100”，其自主研发的斯乐韦米单抗注射液（乐比孚®）凭借突出的临床价值和市场潜力荣获2025未来医疗100强创新奖类“最佳...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165603a47b1d0f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2025未来医疗医药100强展会落幕，智翔金泰双奖加持彰显生物技术创新实力</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2025未来医疗医药100强展会落幕，智翔金泰双奖加持彰显生物技术创新实力\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-12 09:42 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165603a47b1d0f&s=b><strong>智翔金泰生物</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2025年5月9日-10日，由动脉网主办的2025未来医疗医药100强展会（2025VBEF）在苏州国际博览中心举行。大会上，重庆智翔金泰生物制药股份有限公司（简称“智翔金泰”）凭借在生物技术创新领域的卓越表现荣登“2025未来医疗100强医疗健康上市企业创新力排行榜TOP100”，其自主研发的斯乐韦米单抗注射液（乐比孚®）凭借突出的临床价值和市场潜力荣获2025未来医疗100强创新奖类“最佳...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165603a47b1d0f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688443","symbol_name":"智翔金泰","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165603a47b1d0f&s=b","article_id":"2534089214","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512165603a47b1d0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2534089214","pubTimestamp":1747014127,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"大会上，重庆智翔金泰生物制药股份有限公司凭借在生物技术创新领域的卓越表现荣登“2025未来医疗100强医疗健康上市企业创新力排行榜TOP100”，其自主研发的斯乐韦米单抗注射液（乐比孚）凭借突出的临床价值和市场潜力荣获2025未来医疗100强创新奖类“最佳生物技术创新产品”。未来，智翔金泰将继续深耕抗体药物研发创新，持续加大研发投入，加速创新药物的研发进程，为更多患者提供可信赖和可负担的创新生物药。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159891":"医疗","688443":"智翔金泰","000978.SH":"医药100","BK0239":"医药制造","000978":"桂林旅游","BK0241":"公共设施"},"translate_title":"The 2025 Future Medical and Pharmaceutical Top 100 Exhibition ended, and Zhixiang Jintai's double award blessing demonstrated the strength of biotechnology innovation","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159891":1,"688443":1,"000978.SH":1,"000978":0.9},"content_text":"2025年5月9日-10日，由动脉网主办的2025未来医疗医药100强展会（2025VBEF）在苏州国际博览中心举行。大会上，重庆智翔金泰生物制药股份有限公司（简称“智翔金泰”）凭借在生物技术创新领域的卓越表现荣登“2025未来医疗100强医疗健康上市企业创新力排行榜TOP100”，其自主研发的斯乐韦米单抗注射液（乐比孚®）凭借突出的临床价值和市场潜力荣获2025未来医疗100强创新奖类“最佳生物技术创新产品”。创立于2015年的未来医疗100强系列榜单及奖项，历经9年发展，已拓展成为一个涵盖企业、投资机构、医疗机构及产业园区等多维度的全球性创新医疗健康生态评价体系。上市企业创新力排行榜面向医疗健康领域上市企业展开，通过数据剖析企业的创新价值与增长态势，挖掘在创新驱动下，具备高创新力和强劲增长表现的标杆企业。创新奖聚焦生物技术、数字技术、智能医械等领域，遴选兼具技术突破性、临床价值与市场前景的创新成果。作为一家科创板上市企业，智翔金泰始终关注未被满足的临床需求，致力于自身免疫性疾病、感染性疾病和肿瘤三大领域的抗体药物创新研发。斯乐韦米单抗注射液（乐比孚®）是智翔金泰自主研发的重组全人源抗狂犬病病毒双特异性抗体，于2025年1月提交了新药上市申请并获得受理。这款产品也是全球首个用于狂犬病被动免疫的双特异性抗体，未来临床应用前景广阔。本届展会以“THE NOW 临界点”为主题，关注医疗健康产业在挑战与机遇并存的环境下的创新，见证那些敢于立足当下、突破界限的先行者。此次，智翔金泰及其产品获得双重认可，不仅体现了企业的综合竞争力，更是中国医疗健康产业在临界点下创新突破的一个缩影。未来，智翔金泰将继续深耕抗体药物研发创新，持续加大研发投入，加速创新药物的研发进程，为更多患者提供可信赖和可负担的创新生物药。聚焦前沿 共话创新——脊柱关节炎创新发展论坛圆满举办，“智荟风湿”项目盛大开启国产原研1类创新药—赛立奇单抗注射液（金立希®）最新两项研究即将亮相EULAR 2025智翔金泰赛立奇单抗注射液（金立希®）入选国家工信部“2024年未来产业创新发展优秀典型案例”","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2534089214","isCrawlerRequest":true}